Evidence map›Paper›PMID 34902818›Full record

Observational studyPsychiatry research2022

The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study.

Alice Caldiroli, Enrico Capuzzi, Agnese Tringali, Ilaria Tagliabue, Marco Turco, Andrea Fortunato, Matteo Sibilla, Caterina Montana, Laura Maggioni, Cristian Pellicioli and 6 more

Registry-linked trialOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in Psychiatry research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04694482 (The Psychopathological Impact of the SARS-CoV-2 Epidemic on Subjects Suffering From Mental Disorders), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04694482 completednot on this map

The Psychopathological Impact of the SARS-CoV-2 Epidemic on Subjects Suffering From Mental Disorders: Data From ASST Monza

TypeobservationalSponsorUniversity of Milano BicoccaRan2020 to 2021Enrolled270ConditionsPsychosis, Schizophrenic, Personality Disorders, Mood DisordersArmsPsychometric scale administration
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Alice CaldiroliPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy. Electronic address: a.caldiroli@asst-monza.it.
Enrico CapuzziPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Agnese TringaliDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Ilaria TagliabueDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Marco TurcoDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Andrea FortunatoDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Matteo SibillaDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Caterina MontanaDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Laura MaggioniDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Cristian PellicioliDepartment of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
Matteo MarcatiliPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Roberto NavaPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Giovanna CrespiPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Fabrizia ColmegnaPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy.
Massimiliano BuoliDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, Milan 20122, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Massimo ClericiPsychiatric Department, Azienda Socio Sanitaria Territoriale Monza, Via G.B. Pergolesi 33 MB, Monza, Italy; Department of Medicine and Surgery, University of Milan Bicocca, via Cadore 38 MB, Monza 20900, Italy.
University of Milano-Bicocca · ITAzienda Socio Sanitaria Territoriale Lariana · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infection causes a pulmonary disease (COVID-19) which spread worldwide generating fear, anxiety, depression in the general population as well as among subjects affected by mental disorders. Little is known about which different psychopathological changes the pandemic caused among individuals affected by different psychiatric disorders, which represents the aim of the present study. Specific psychometric scales were administered at three time points: T0 as outbreak of pandemic, T1 as lockdown period, T2 as reopening. Descriptive analyses and linear regression models were performed. A total of 166 outpatients were included. Overall, psychometric scores showed a significant worsening at T1 with a mild improvement at T2. Only psychopathology in schizophrenia (SKZ) patients and obsessive-compulsive (OC) symptoms did not significantly improve at T2. Subjects affected by personality disorders (PDs) resulted to be more compromised in terms of general psychopathology than depressed and anxiety/OC ones, and showed more severe anxiety symptoms than SKZ patients. In conclusion, subjects affected by PDs require specific clinical attention during COVID-19 pandemic. Moreover, the worsening of SKZ and OC symptoms should be strictly monitored by clinicians, as these aspects did not improve with the end of lockdown measures. Further studies on larger samples are needed to confirm our results. ClinicalTrials.gov Identifier: NCT04694482.

Indexed as

COVID-19Mental DisordersAnxietyCommunicable Disease ControlHumansPandemicsRetrospective StudiesSARS-CoV-2COVID-19Obsessive-compulsive symptomsOutpatientsPandemicPersonality disordersPsychotic symptoms

Identifiers

PMID34902818
PMCPMC8664498
OpenAlexW4200090964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.